Stockreport

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of Human Genetics 2024 Annual Me...

Rallybio Corporation  (RLYB) 
PDF – Results Indicate that FNAIT Risk is More Prevalent Than Previously Estimated – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-st [Read more]